• Profile
Close

Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation

BMC Infectious Diseases Sep 28, 2017

Harada K, et al. - Authors here aimed at assessing factors associated with poor prognosis of allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients with Stenotrophomonas maltophilia (S. maltophilia) bacteremia. Findings revealed higher rates of S. maltophilia bacteremia among allo-HSCT recipients than patients not receiving allo-HSCT. In this study, high serum C-reactive protein (CRP) and low serum albumin at the onset of bacteremia proved predictive of disease progression to pneumonia and poor prognosis.

Methods

  • Authors examined patients with hematological diseases and S. maltophilia bacteremia for incidence and 90-day mortality in Japan from January 2005 to December 2014 .
  • They performed analysis of prognostic factors associated with 90-day mortality among allo-HSCT recipients by log-rank test.
  • Significant variables in the univariate analysis were included in the multivariate Cox proportional-hazards regression model.

Results

  • In this study, a total of 65 patients, including 47 patients undergoing allo-HSCT, developed S. maltophilia bacteremia.
  • Significantly higher incidence of S. maltophilia bacteremia was observed in allo-HSCT recipients compared to patients not receiving allo-HSCT (6.53 vs. 0.36 per 100 admissions, respectively; p < 0.01).
  • In allo-HSCT recipients, findings revealed an overall 90-day mortality of 43%.
  • For 90-day mortality, independent risk factors included low serum albumin (<3.0 g/dl) (HR = 10.86; 95% CI, 3.27–36.12) and high serum C-reactive protein (CRP) (≥10.0 mg/dl) (HR = 3.28; 95% CI, 1.00-10.72).
  • Among 9 patients with both high CRP and low albumin, 5 indicated pneumonia at the onset of bacteremia and the remaining 4 patients developed pneumonia in a median of 3 days (range, 1 to 8 days) even under effective treatment.
  • In a median period of 2 days (range, 2 to 32 days), all 9 patients eventually died.
  • In patients with or without high CRP and low albumin levels, the probabilities of developing pneumonia were 100% (9/9) and 10.5% (4/38), respectively (p < 0.01).

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay